NervGen Pharma Corp. (NGEN)
NGEN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.63
-5.78% on the day
Market cap
$173.5M
Micro cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | NGEN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001751912 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A1 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 40-F | 2026-03-31 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-09-25 |
Source: SEC EDGAR submissions feed, 39 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ORMP | Oramed Pharmaceuticals Inc. | $4.17 | -2.34% | $173.5M |
| PEPG | PepGen Inc. | $2.50 | +0.40% | $173.1M |
| YARW | Yarrow Bioscience Inc. | $18.60 | -6.16% | $173.1M |
| WHWK | Whitehawk Therapeutics Inc. | $3.02 | -10.65% | $172.2M |
| VRXA | Veraxa Biotech AG | $1.20 | +5.26% | $169.7M |
| LYEL | Lyell Immunopharma Inc. | $7.51 | -9.19% | $184.0M |
| ADAG | Adagene Inc. | $2.46 | -10.22% | $162.5M |
| CNTN | Canton Strategic Holdings Inc. | $2.02 | -4.26% | $161.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier